180 Life Sciences (ATNF) News Today $2.28 -0.06 (-2.56%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period 180 Life Sciences files to sell 1.9M shares of common stock for holdersNovember 16, 2024 | markets.businessinsider.com180 Life Sciences files for secondary offering of common stockNovember 16, 2024 | msn.com180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform IntegrationOctober 31, 2024 | finance.yahoo.com180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of DirectorsOctober 30, 2024 | finance.yahoo.comElray Resources Announces Strategic Sale of Crypto iGaming TechnologyOctober 25, 2024 | markets.businessinsider.comSoaring $1-handle stocks leaping into IBKR’s most-active list may point to market frothOctober 23, 2024 | msn.com180 Life Sciences' Brave Decision To Switch to the iGaming IndustryOctober 18, 2024 | finance.yahoo.com180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial OfficerSeptember 12, 2024 | globenewswire.com180 Life Sciences Corp Ordinary SharesSeptember 3, 2024 | morningstar.com180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral UptakeJuly 30, 2024 | globenewswire.com180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing RequirementsJuly 23, 2024 | finance.yahoo.com180 Life Sciences Corp. (ATNFW)May 18, 2024 | finance.yahoo.com180 Life Sciences Corp.: 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementMarch 14, 2024 | finanznachrichten.de180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementMarch 14, 2024 | finance.yahoo.com180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementMarch 14, 2024 | globenewswire.comTrading was temporarily halted for "ATNF" at 07:02 PM with a stated reason of "News pending."February 28, 2024 | marketbeat.com180 Life Sciences Announces 1-For 19 Reverse Stock Split - Quick FactsFebruary 26, 2024 | markets.businessinsider.com180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance PlanFebruary 26, 2024 | globenewswire.com180 Life Sciences Corp.February 17, 2024 | thestreet.com180 Life Sciences Stock (NASDAQ:ATNF), Quotes and News SummaryDecember 20, 2023 | benzinga.com180 Life Sciences Hires Financial Adviser to Help Explore Strategic AlternativesDecember 4, 2023 | marketwatch.com180 Life Sciences Engages Financial Advisor to Explore Strategic AlternativesDecember 4, 2023 | finance.yahoo.com180 Life Sciences Corp.: 180 Life Sciences Announces Review of Strategic AlternativesNovember 28, 2023 | finanznachrichten.de180 Life Sciences Announces Review of Strategic AlternativesNovember 28, 2023 | finance.yahoo.com180 Life Sciences Corp. Common Stock (ATNF)October 7, 2023 | nasdaq.comInnovative Biotech Company Announces Agreement To Perform CBD Pill Clinical StudySeptember 15, 2023 | benzinga.com180 Life Sciences Corp. Announces Closing of $3 Million Public OfferingAugust 14, 2023 | finance.yahoo.com180 Life Sciences Teams Up With Hadassah Hospital To Test A New Formulation Of CBD For Enhanced Oral UptakeAugust 7, 2023 | benzinga.com180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral UptakeAugust 7, 2023 | finance.yahoo.com180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDAAugust 3, 2023 | finance.yahoo.com180 Life Sciences Files A Provisional Patent For CBD-Based Appetite SuppressantJuly 31, 2023 | benzinga.com180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress AppetiteJuly 31, 2023 | finance.yahoo.com180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private PlacementApril 10, 2023 | finance.yahoo.com180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private PlacementApril 5, 2023 | finance.yahoo.comTrading was temporarily halted for "ATNF" at 01:04 PM with a stated reason of "LULD pause."April 5, 2023 | marketbeat.comWhy Is 180 Life Sciences (ATNF) Stock Up 30% Today?April 5, 2023 | investorplace.com180 Life Sciences Announces Presentation at the Gordon ConferenceFebruary 28, 2023 | finance.yahoo.com180 Life Sciences Announces Presentation at the Gordon ConferenceFebruary 27, 2023 | finance.yahoo.com180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and ApplicationFebruary 23, 2023 | finance.yahoo.com180 Life Sciences stock dips as recruitment in trial for Frozen shoulder closes amid challengesFebruary 23, 2023 | seekingalpha.com180 Life Sciences to get US patent linked to treating hand disorder DupuytrenFebruary 23, 2023 | seekingalpha.com180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and ApplicationFebruary 23, 2023 | finance.yahoo.com180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder TrialFebruary 22, 2023 | benzinga.com180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder TrialFebruary 22, 2023 | finance.yahoo.comTrading was temporarily halted for "ATNF" at 01:02 PM with a stated reason of "LULD pause."February 2, 2023 | marketbeat.com180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s DiseaseJanuary 25, 2023 | finance.yahoo.com180 Life Sciences up 12% on tumor necrosis factor as target for Dupuytren’s diseaseJanuary 25, 2023 | msn.com180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s DiseaseJanuary 25, 2023 | finance.yahoo.com180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United KingdomJanuary 17, 2023 | finance.yahoo.comNewman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)January 10, 2023 | wsj.com Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. ATNF Media Mentions By Week ATNF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATNF News Sentiment▼0.300.48▲Average Medical News Sentiment ATNF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATNF Articles This Week▼20▲ATNF Articles Average Week Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AYTU News Today JAGX News Today RDHL News Today ADXN News Today VINC News Today SNGX News Today MBRX News Today ENSC News Today ATHE News Today COEP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATNF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
